MTaPS Malaria Fact Sheet

WHO’s Global Technical Strategy (GTS) for Malaria 2016–2030 aims to reduce global malaria incidence and deaths by at least 90% by 2030. To achieve these targets, high malaria burden countries need strong national pharmaceutical systems that can support the effective implementation of key malaria interventions. According to the World Malaria Report 2018, WHO, the RBM Partnership to End Malaria, and other partners will support the new country-driven approach to jumpstart progress against malaria founded on four pillars: galvanize national and global political attention to reduce malaria deaths; drive impact in country through the strategic use of information; establish best global guidance, policies, and strategies suitable for all malaria endemic countries; implement a coordinated country response. USAID MTaPS will support countries seeking to achieve the GTS target using the “High burden to high impact” approach by strengthening their pharmaceutical sectors.